Magnitude of Antibody Cross-Reactivity in Medically Important Mosquito-Borne Flaviviruses: A Systematic Review

References

• Huang YJ, Higgs S, Horne KM, Vanlandingham DL. Flavivirus-mosquito interactions. Viruses. 2014;6(11):4703–4730. doi:10.3390/v611470325421894
   PubMed Web of Science ®Google Scholar
• Gubler DJ, Markoff L. 2007 flaviviruses. In: Knipe DM, Howley PM, editors. Fields Virology. 5th ed. Vol. 1. Philadelphia, PA: Lippincott Williams & Wilkins; 2007.
   Google Scholar
• Simmonds P, Becher P, Bukh J, et al. ICTV virus taxonomy profile: flaviviridae. J Gen Virol. 2017;98(1):2–3. doi:10.1099/jgv.0.00067228218572
   PubMed Web of Science ®Google Scholar
• Mota MT, Terzian AC, Silva ML, Estofolete C, Nogueira ML. Mosquito-transmitted viruses - the great Brazilian challenge. Braz J Microbiol. 2016;47(Suppl 1):38–50. doi:10.1016/j.bjm.2016.10.00827818091
   PubMed Web of Science ®Google Scholar
• Diosa-Toro M, Urcuqui-Inchima S, Smit JM. Arthropod-borne flaviviruses and RNA interference: seeking new approaches for antiviral therapy. Adv Virus Res. 2013;85:91–111.23439025
   PubMed Web of Science ®Google Scholar
• Calzolari M, Ze-Ze L, Vazquez A, Sanchez Seco MP, Amaro F, Dottori M. Insect-specific flaviviruses, a worldwide widespread group of viruses only detected in insects. Infect Genet Evol. 2016;40:381–388. doi:10.1016/j.meegid.2015.07.03226235844
   PubMed Web of Science ®Google Scholar
• Holbrook MR. Historical perspectives on flavivirus research. Viruses. 2017;9(5):97. doi:10.3390/v9050097
   Web of Science ®Google Scholar
• Chambers TJ, Hahn CS, Galler R, Rice CM. Flavivirus genome organization, expression, and replication. Annu Rev Microbiol. 1990;44:649–688. doi:10.1146/annurev.mi.44.100190.0032452174669
   PubMed Web of Science ®Google Scholar
• Crill WD, Chang GJ. Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes. J Virol. 2004;78(24):13975–13986. doi:10.1128/JVI.78.24.13975-13986.200415564505
   PubMed Web of Science ®Google Scholar
• Volk DE, May FJ, Gandham SH, et al. Structure of yellow fever virus envelope protein domain III. Virology. 2009;394(1):12–18. doi:10.1016/j.virol.2009.09.00119818466
   PubMed Web of Science ®Google Scholar
• Cherrier MV, Kaufmann B, Nybakken GE, et al. Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibody. EMBO J. 2009;28(20):3269–3276. doi:10.1038/emboj.2009.24519713934
   PubMed Web of Science ®Google Scholar
• Chavez JH, Silva JR, Amarilla AA, Moraes Figueiredo LT. Domain III peptides from flavivirus envelope protein are useful antigens for serologic diagnosis and targets for immunization. Biologicals. 2010;38(6):613–618. doi:10.1016/j.biologicals.2010.07.00420817489
   PubMed Web of Science ®Google Scholar
• Matsui K, Gromowski GD, Li L, Barrett AD. Characterization of a dengue type-specific epitope on dengue 3 virus envelope protein domain III. J Gen Virol. 2010;91(Pt 9):2249–2253. doi:10.1099/vir.0.021220-020444995
   PubMed Web of Science ®Google Scholar
• Roehrig JT, Butrapet S, Liss NM, et al. Mutation of the dengue virus type 2 envelope protein heparan sulfate binding sites or the domain III lateral ridge blocks replication in Vero cells prior to membrane fusion. Virology. 2013;441(2):114–125. doi:10.1016/j.virol.2013.03.01123571092
   PubMed Web of Science ®Google Scholar
• Heinz FX, Stiasny K. Flaviviruses and flavivirus vaccines. Vaccine. 2012;30(29):4301–4306. doi:10.1016/j.vaccine.2011.09.11422682286
   PubMed Web of Science ®Google Scholar
• Koraka P, Zeller H, Niedrig M, Osterhaus AD, Groen J. Reactivity of serum samples from patients with a flavivirus infection measured by immunofluorescence assay and ELISA. Microbes Infect. 2002;4(12):1209–1215. doi:10.1016/S1286-4579(02)01647-712467761
   PubMed Web of Science ®Google Scholar
• Hobson-Peters J. Approaches for the development of rapid serological assays for surveillance and diagnosis of infections caused by zoonotic flaviviruses of the Japanese encephalitis virus serocomplex. J Biomed Biotechnol. 2012;2012:379738. doi:10.1155/2012/37973822570528
   PubMedGoogle Scholar
• Thomas SJ, Nisalak A, Anderson KB, et al. Dengue plaque reduction neutralization test (PRNT) in primary and secondary dengue virus infections: how alterations in assay conditions impact performance. Am J Trop Med Hyg. 2009;81(5):825–833. doi:10.4269/ajtmh.2009.08-062519861618
   PubMed Web of Science ®Google Scholar
• Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100. doi:10.1371/journal.pmed.100010019621070
   PubMed Web of Science ®Google Scholar
• Mansfield KL, Horton DL, Johnson N, et al. Flavivirus-induced antibody cross-reactivity. J Gen Virol. 2011;92(Pt 12):2821–2829. doi:10.1099/vir.0.031641-021900425
   PubMed Web of Science ®Google Scholar
• Allwinn R, Doerr HW, Emmerich P, Schmitz H, Preiser W. Cross-reactivity in flavivirus serology: new implications of an old finding? Med Microbiol Immunol. 2002;190(4):199–202. doi:10.1007/s00430-001-0107-912005333
   PubMed Web of Science ®Google Scholar
• van Meer MPA, Mogling R, Klaasse J, et al. Re-evaluation of routine dengue virus serology in travelers in the era of Zika virus emergence. J Clin Virol. 2017;92:25–31. doi:10.1016/j.jcv.2017.05.00128505571
   PubMed Web of Science ®Google Scholar
• Houghton-Trivino N, Montana D, Castellanos J. Dengue-yellow fever sera cross-reactivity; challenges for diagnosis. Revista de salud publica. 2008;10(2):299–307. doi:10.1590/S0124-0064200800020001019039426
   PubMedGoogle Scholar
• Kam YW, Pok KY, Eng KE, et al. Sero-prevalence and cross-reactivity of chikungunya virus specific anti-E2EP3 antibodies in arbovirus-infected patients. PLoS Negl Trop Dis. 2015;9(1):e3445. doi:10.1371/journal.pntd.000344525568956
   PubMed Web of Science ®Google Scholar
• Makino Y, Tadano M, Saito M, et al. Studies on serological cross-reaction in sequential flavivirus infections. Microbiol Immunol. 1994;38(12):951–955. doi:10.1111/j.1348-0421.1994.tb02152.x7723688
   PubMed Web of Science ®Google Scholar
• Lai CY, Tsai WY, Lin SR, et al. Antibodies to envelope glycoprotein of dengue virus during the natural course of infection are predominantly cross-reactive and recognize epitopes containing highly conserved residues at the fusion loop of domain II. J Virol. 2008;82(13):6631–6643. doi:10.1128/JVI.00316-0818448542
   PubMed Web of Science ®Google Scholar
• Lai L, Rouphael N, Xu Y, et al. Innate, T-, and B-cell responses in acute human zika patients. Clin Infect Dis. 2018;66(1):1–10. doi:10.1093/cid/cix73229020226
   PubMed Web of Science ®Google Scholar
• Lanciotti RS, Kosoy OL, Laven JJ, et al. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis. 2008;14(8):1232–1239. doi:10.3201/eid1408.08028718680646
   PubMed Web of Science ®Google Scholar
• Priyamvada L, Suthar MS, Ahmed R, Wrammert J. Humoral immune responses against zika virus infection and the importance of preexisting flavivirus immunity. J Infect Dis. 2017;216(suppl_10):S906–S911. doi:10.1093/infdis/jix51329267924
   PubMed Web of Science ®Google Scholar
• Rogers TF, Goodwin EC, Briney B, et al. Zika virus activates de novo and cross-reactive memory B cell responses in dengue-experienced donors. Sci Immunol. 2017;2(14):eaan6809. doi:10.1126/sciimmunol.aan680928821561
   PubMed Web of Science ®Google Scholar
• Stettler K, Beltramello M, Espinosa DA, et al. Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection. Science. 2016;353(6301):823–826. doi:10.1126/science.aaf850527417494
   PubMed Web of Science ®Google Scholar
• Souza N, Felix AC, de Paula AV, Levi JE, Pannuti CS, Romano CM. Evaluation of serological cross-reactivity between yellow fever and other flaviviruses. IJID. 2019;81:4–5.30660799
   PubMed Web of Science ®Google Scholar
• Priyamvada L, Quicke KM, Hudson WH, et al. Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus. Proc Natl Acad Sci U S A. 2016;113(28):7852–7857. doi:10.1073/pnas.160793111327354515
   PubMed Web of Science ®Google Scholar
• Priyamvada L, Cho A, Onlamoon N, et al. B cell responses during secondary dengue virus infection are dominated by highly cross-reactive, memory-derived plasmablasts. J Virol. 2016;90(12):5574–5585. doi:10.1128/JVI.03203-1527030262
   PubMed Web of Science ®Google Scholar
• Robert E, Shope PW, Amelia Travassosd AR. The Arboviruses: Epidemiology and Ecology. CRC Press; 1988:38.
   Google Scholar
• Vazquez S, Valdes O, Pupo M, et al. MAC-ELISA and ELISA inhibition methods for detection of antibodies after yellow fever vaccination. J Virol Methods. 2003;110(2):179–184. doi:10.1016/S0166-0934(03)00128-912798246
   PubMed Web of Science ®Google Scholar
• Rastogi M, Sharma N, Singh SK. Flavivirus NS1: a multifaceted enigmatic viral protein. Virol J. 2016;13:131. doi:10.1186/s12985-016-0590-727473856
   PubMed Web of Science ®Google Scholar
• Simmons G, Stone M, Busch MP. Arbovirus diagnostics: from bad to worse due to expanding dengue virus vaccination and zika virus epidemics. Clin Infect Dis. 2018;66(8):1181–1183. doi:10.1093/cid/cix97229301009
   PubMed Web of Science ®Google Scholar
• Ratnam S, Gadag V, West R, et al. Comparison of commercial enzyme immunoassay kits with plaque reduction neutralization test for detection of measles virus antibody. J Clin Microbiol. 1995;33(4):811–815. doi:10.1128/jcm.33.4.811-815.19957790442
   PubMed Web of Science ®Google Scholar
• Sirivichayakul C, Sabchareon A, Limkittikul K, Yoksan S. Plaque reduction neutralization antibody test does not accurately predict protection against dengue infection in Ratchaburi cohort, Thailand. Virol J. 2014;11:48. doi:10.1186/1743-422X-11-4824620925
   PubMed Web of Science ®Google Scholar